BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31374558)

  • 1. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.
    Eulitz J; Lutz B; Wohlfahrt P; Dutz A; Enghardt W; Karpowitz C; Krause M; Troost EGC; Lühr A
    Phys Med Biol; 2019 Nov; 64(22):225020. PubMed ID: 31374558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double scattering and pencil beam scanning Monte Carlo workflows for proton therapy retrospective studies on radiation-induced toxicities.
    Leite AMM; Bonfrate A; Da Fonseca A; Lansonneur P; Alapetite C; Mammar H; De Marzi L
    Cancer Radiother; 2023 Jun; 27(4):319-327. PubMed ID: 37164897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field dose.
    Tjelta J; Fjæra LF; Ytre-Hauge KS; Boer CG; Stokkevåg CH
    Phys Med Biol; 2023 Nov; 68(22):. PubMed ID: 37820690
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical dose assessment for scanned carbon-ion radiotherapy using linear energy transfer measurements and Monte Carlo simulations.
    Nakaji T; Kanai T; Takashina M; Matsumura A; Osaki K; Yagi M; Tsubouchi T; Hamatani N; Ogawa K
    Phys Med Biol; 2022 Dec; 67(24):. PubMed ID: 36327456
    [No Abstract]   [Full Text] [Related]  

  • 7. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.
    Peeler CR; Mirkovic D; Titt U; Blanchard P; Gunther JR; Mahajan A; Mohan R; Grosshans DR
    Radiother Oncol; 2016 Dec; 121(3):395-401. PubMed ID: 27863964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients.
    Eulitz J; G C Troost E; Klünder L; Raschke F; Hahn C; Schulz E; Seidlitz A; Thiem J; Karpowitz C; Hahlbohm P; Grey A; Engellandt K; Löck S; Krause M; Lühr A
    Radiother Oncol; 2023 Jan; 178():109422. PubMed ID: 36435337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Contrast Enhancing Brain Lesions in Proton-Treated Patients With Low-Grade Glioma: Clinical Evidence for Increased Periventricular Sensitivity and Variable RBE.
    Bahn E; Bauer J; Harrabi S; Herfarth K; Debus J; Alber M
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):571-578. PubMed ID: 32234554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study.
    Hahn C; Ödén J; Dasu A; Vestergaard A; Fuglsang Jensen M; Sokol O; Pardi C; Bourhaleb F; Leite A; de Marzi L; Smith E; Aitkenhead A; Rose C; Merchant M; Kirkby K; Grzanka L; Pawelke J; Lühr A
    Acta Oncol; 2022 Feb; 61(2):206-214. PubMed ID: 34686122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Range uncertainty in proton therapy due to variable biological effectiveness.
    Carabe A; Moteabbed M; Depauw N; Schuemann J; Paganetti H
    Phys Med Biol; 2012 Mar; 57(5):1159-72. PubMed ID: 22330133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phenomenological relative biological effectiveness approach for proton therapy based on an improved description of the mixed radiation field.
    Mairani A; Dokic I; Magro G; Tessonnier T; Bauer J; Böhlen TT; Ciocca M; Ferrari A; Sala PR; Jäkel O; Debus J; Haberer T; Abdollahi A; Parodi K
    Phys Med Biol; 2017 Feb; 62(4):1378-1395. PubMed ID: 28114106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.